Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.51
Bid: 2.46
Ask: 2.56
Change: 0.04 (1.62%)
Spread: 0.10 (4.065%)
Open: 2.47
High: 0.00
Low: 0.00
Prev. Close: 2.47
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results & Preliminary H1 Financials

30 Aug 2019 07:00

RNS Number : 6298K
Globalworth Real Estate Inv Ltd
30 August 2019
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this information is considered to be in the public domain.

 

30 August 2019

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

Notice of Interim Results & Preliminary Interim Financial Information

Globalworth announces that it intends to publish its Interim Report and Financial Statements for the six-month period ended 30 June 2019 during the week commencing 16 September 2019. Ahead of this publication, the Company is today providing a preliminary release of its unaudited Consolidated Statement of Comprehensive Income and unaudited Consolidated Statement of Financial Position to 30 June 2019.

In addition, the Company is pleased to report its preliminary EPRA Net Asset Value as at 30 June 2019 to be €1,754 million or €9.05 per share.

For further information visit www.globalworth.com or contact: 

Enquiries 

Andrew Cox Tel: +44 20 3026 4027

Head of Investor Relations & Corporate Development

Jefferies (Joint Broker) Tel: +44 20 7029 8000

Stuart Klein

Panmure Gordon (Nominated Adviser and Joint Broker) Tel: +44 20 7886 2500

Alina Vaskina/Justin Gulston

Milbourne (Public Relations) Tel: +44 7903 802545

Tim Draper

About Globalworth / Note to Editors: 

Globalworth is a listed real estate company active in Central and Eastern Europe, quoted on the AIM-segment of the London Stock Exchange. It has become the pre-eminent office investor in the CEE real estate market through its market-leading positions both in Romania and in Poland, where the Company has a >99% shareholding in Globalworth Poland, a pure-play Polish real estate platform listed on the Warsaw Stock Exchange. Globalworth acquires, develops and directly manages high-quality office and logistics/light-industrial real estate assets in prime locations, generating rental income from high quality tenants from around the globe. Managed by over 200 professionals across Romania and Poland, the combined value of its portfolio is over €2.7 billion, as at 31 December 2018 and proforma for subsequent acquisitions. Over 90% of the portfolio is in income-producing assets, predominately in the office sector, and leased to a diversified array of some 650 national and multinational corporates. In Romania, Globalworth is present in Bucharest, Timisoara and Pitesti, while in Poland its assets span Warsaw, Wroclaw, Lodz, Krakow, Gdansk and Katowice. For more information, please visit www.globalworth.com and follow us on Facebook, Instagram and LinkedIn.

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 JUNE 2019

 

 

 

30 June

 2019

30 June

2018

 

 

 

 

Unaudited €'000

Unaudited €'000

 

 

Revenue

 

103,792

78,097

 

 

Operating expenses

 

(35,790)

(26,398)

 

 

Net operating income

 

68,002

51,699

 

 

Administrative expenses

 

(6,984)

(6,456)

 

 

Acquisition costs

 

(15)

(952)

 

 

Fair value gain on investment property

 

49,049

38,558

 

 

Gain on acquisition of subsidiaries

 

-

251

 

 

Share-based payment expense

 

(390)

(97)

 

 

Depreciation on other long-term assets

 

(159)

(179)

 

 

Other expenses

 

(6,548)

(1,494)

 

 

Other income

 

615

215

 

 

Foreign exchange loss

 

(553)

(883)

 

 

Gain from fair value of financial instruments

 

1,569

1,653

 

 

 

 

36,584

30,616

 

 

Profit before net financing cost

 

104,586

82,315

 

 

Net financing cost

 

 

 

 

 

Finance cost

 

(22,629)

(20,505)

 

 

Finance income

 

1,691

1,425

 

 

 

 

(20,938)

(19,080)

 

 

Share of profit of equity-accounted investments in joint ventures

 

4,384

717

 

 

Profit before tax

 

88,032

63,952

 

 

Income tax expense

 

(12,150)

(7,573)

 

 

Profit for the period

 

75,882

56,379

 

 

Other comprehensive income

 

-

-

 

 

Profit attributable to:

 

75,882

56,379

 

 

- Equity holders of the Company

 

69,902

49,766

 

 

- Non-controlling interests

 

5,980

6,613

 

 

 

 

 

 

 

 

 

 

 

 

 

       

 

 

 

 

INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2019

 

 

30 June

 2019

31 December 2018

 

 

 

Unaudited

Audited

 

 

 

€'000

€'000

 

ASSETS

 

 

 

 

Non-current assets

 

 

 

 

Investment property- freehold

 

2,639,345

2,390,994

 

Investment property - leasehold

 

31,079

-

 

Goodwill

 

12,349

12,349

 

Advances for investment property

 

5,396

4,209

 

Investments in joint-ventures

 

48,183

38,316

 

Equity investments

 

9,483

8,837

 

Other long-term assets

 

1,520

1,035

 

Prepayments

 

1,409

1,472

 

Financial assets at fair value through profit or loss

 

2,854

2,829

 

 

 

2,751,618

2,460,041

 

Current assets

 

 

 

 

Financial assets at fair value through profit or loss

 

20,402

12,878

 

Trade and other receivables

 

22,595

25,281

 

Contract assets

 

4,622

3,937

 

Guarantees retained by tenants

 

12

11

 

Income tax receivable

 

422

395

 

Prepayments

 

2,890

4,929

 

Cash and cash equivalents

 

396,271

229,527

 

 

 

447,214

276,958

 

Total assets

 

3,198,832

2,736,999

 

 

 

 

 

 

EQUITY AND LIABILITIES

 

 

 

 

Total equity

 

 

 

 

Issued share capital

 

1,414,464

897,314

 

Treasury shares

 

(3,581)

(842)

 

Share-based payment reserve

 

31,778

2,117

 

Retained earnings

 

171,341

186,326

 

Equity attributable to equity holders of the Company

 

1,614,002

1,084,915

 

Non-controlling interests

 

1,186

212,407

 

 

 

1,615,188

1,297,322

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

Interest-bearing loans and borrowings

 

1,260,710

1,235,106

 

Deferred tax liability

 

116,428

106,978

 

Lease liabilities

 

28,990

-

 

Guarantees retained from contractors

 

621

693

 

Deposits from tenants

 

12,133

13,754

 

Provision for tenant lease incentives

 

602

780

 

Trade and other payables

 

1,557

694

 

 

 

1,421,041

1,358,005

 

 

 

 

 

 

Current liabilities

 

 

 

 

Interest-bearing loans and borrowings

 

82,048

23,965

 

Guarantees retained from contractors

 

3,611

3,353

 

Trade and other payables

 

64,110

32,956

 

Contract liability

 

1,501

1,401

 

Other current financial liabilities

 

1,906

2,084

 

Deposits from tenants

 

4,777

2,241

 

Provision for tenant lease incentives

 

1,538

1,211

 

Current portion of lease liabilities

 

2,089

-

 

Dividends payable

 

26

10,731

 

Income tax payable

 

997

3,730

 

 

 

162,603

81,672

 

Total equity and liabilities

 

3,198,832

2,736,999

 

 

IMPORTANT NOTICE: This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom. This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCVKLFLKVFFBBF
Date   Source Headline
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM
1st Jun 20224:20 pmRNSEUR85 million loan agreement with the IFC
17th May 20225:27 pmRNSNotice of AGM and Availability of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.